Ovarian cancer drug combo study halted early
NCT ID NCT05756907
First seen Feb 03, 2026 · Last updated May 19, 2026 · Updated 12 times
Summary
This study tested a combination of two drugs, SON-1010 and atezolizumab, in people with advanced solid tumors and platinum-resistant ovarian cancer. The goal was to see if the combo was safe and could slow cancer growth. The study was terminated early, so results are limited. It involved about 40 adults who had already tried standard treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Ashford Cancer Centre Research
Kurralta Park, South Australia, 5037, Australia
-
Blacktown Mt Druitt Hospital
Blacktown, New South Wales, 2148, Australia
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
-
Sarcoma Oncology Center
Santa Monica, California, 90403, United States
-
The Border Cancer Hospital
Albury, New South Wales, 2640, Australia
-
University of Southern California
Los Angeles, California, 90033, United States
Conditions
Explore the condition pages connected to this study.